Alvaro
Lassaletta Atienza
Consultor Médico
German Cancer Research Center
Heidelberg, AlemaniaPublicaciones en colaboración con investigadores/as de German Cancer Research Center (6)
2023
-
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial
JAMA Oncology, Vol. 9, Núm. 12, pp. 1688-1695
2017
-
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Cancer Cell, Vol. 31, Núm. 6, pp. 737-754.e6
-
Pediatric low-grade gliomas: Implications of the biologic era
Neuro-Oncology, Vol. 19, Núm. 6, pp. 750-761
2016
-
No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patients
Human Genetics, Vol. 135, Núm. 5, pp. 469-475
-
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
The Lancet Oncology, Vol. 17, Núm. 4, pp. 484-495
-
Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: A retrospective multicohort analysis
Journal of Clinical Oncology, Vol. 34, Núm. 21, pp. 2468-2477